AdamSCheifetzMD
Gastroenterology • Boston, MAInflammatory Bowel Disease
Director, Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center; Professor of Medicine, Harvard Medical School
Dr. Cheifetz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Beth Israel Deaconess Medical Center
Boston, MA 02215Phone+1 617-667-2082
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2003 - 2004
Yale-New Haven Medical CenterFellowship, Gastroenterology, 2001 - 2004- Yale-New Haven Medical CenterResidency, Internal Medicine, 1997 - 2000
Weill Cornell MedicineClass of 1997
Certifications & Licensure
MA State Medical License 2004 - 2025
CT State Medical License 2000 - 2005- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2008-2013
- Fellow (AGAF) American Gastroenterological Association, 2012
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 270 citationsThe risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease.Adam S. Cheifetz, Asher Kornbluth, Peter Legnani, Ira Schmelkin, Alphonso Brown
The American Journal of Gastroenterology. 2006-07-18 - 20 citationsMeta-Analysis of the Placebo Response in Ulcerative ColitisSagar Garud, Alphonso Brown, Adam S. Cheifetz, Emily B. Levitan, Ciaran P. Kelly
Digestive Diseases and Sciences. 2008-04-01 - 34 citationsA Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel DiseaseLaurie B. Grossberg, Konstantinos Papamichael, Joseph D. Feuerstein, Corey A. Siegel, Thomas A. Ullman
Inflammatory Bowel Diseases. 2018-01-01
Journal Articles
- Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel DiseaseByron P Vaughn, Adam S Cheifetz, Digestive Diseases and Sciences
Lectures
- Advances in Gastroenterology - 2013Harvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 6/10/2013
- Gastroenterology in the 21st Century: Optimizing Patient OutcomesOMICS Publishing Group, Boston, Massachusetts - 5/7/2013
Other
- Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel diseaseCheifetz AS, Cullen GJ
http://www.uptodate.com/contents/sulfasalazine-and-5-aminosalicylates-in-the-treatment-of-inflammato
UpToDate, Wolters Kluwer Health - 2012-12-06
Press Mentions
Dealing with Crohn's Disease During PregnancyJuly 28th, 2020- Top in GI: Telehealth, IBD Treatment SelectionJuly 24th, 2020
- Bacainn Therapeutics Announces IND Clearance for BT051 and Initiation of Phase 1 Clinical Trial, Bacainn’s First Clinical Candidate for the Treatment of Ulcerative ColitisJune 9th, 2020
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
